Blood cancers, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at resminostat for T cell lymphoma of the skin. It was for people whose lymphoma hadn’t got worse after their last treatment.
The trial was open for people to join between 2017 and 2022. The team presented the results at a conference in 2023.
Recruitment start: 9 January 2017
Recruitment end: 11 May 2022
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Julia Scarisbrick
4SC AG
Last reviewed: 25 Apr 2024
CRUK internal database number: 15513
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
